Japan In Vitro Diagnostics (IVD) Market, By Diagnostics, Companies, Reimbursements, Porter's Model, Growth Drivers, Opportunities Challenges

Japan In Vitro Diagnostics (IVD) Market, By Diagnostics, Companies, Reimbursements, Porter's Model, Growth Drivers, Opportunities Challenges

As most of the industry growth rate in Japan is hit due to COVID-19, but on the contrary, Japan In-Vitro Diagnostics Market is expected to put an exceptional higher growth rate in 2020 compared to its past years (read the report for Coronavirus impact on IVD industry of Japan). According to our research report, Japan In-vitro Diagnostic Market is projected to reach US$ 4.43 Billion by 2026.

In-vitro Diagnostics falls under the medical devices segment, which is used by disposable & consumable, and it is also used in many different, different types of medical tones to find multiple bio-samples. In recent years, several developments have happened in the field of In-vitro diagnostics like conventional diagnostics to new generation gene diagnostics. This has become possible with the advent of new technologies, such as genetic testing, chain reaction (PCR), next-generation sequencing (NGS), and molecular diagnostics.

Factors driving the IVD Market in Japan

In Japan, a quarter of its population age 65 years & above and also has the highest proportion of the aging population across the globe. The main problem faced by the Japanese government in recent years is the rise in the number of an aging population, as the cases of aging diseases are multiplying. Accordingly, the Japanese government has given priority to deal with the aging population, and the government is expected to devote an expanded health budget to aging by 2025. This will boost the future of the Japanese In-Vitro Diagnostics Industry by rising prevalence and increased public expenditure.

Apart from that enhanced diagnostic technology, people's awareness and the subsequent growth in the prevalence of chronic and infectious diseases, a rise in the number of private hospitals, and independent testing laboratories are also some of the other factors that contribute to its market growth. Japan's clinical laboratory markets represent one of the largest and fastest-growing markets among the top ten IVD nation markets in the Asia Pacific regions.

Renub Research report titled “Japan In Vitro Diagnostics (IVD) Market, By Diagnostics (Tumor Marker, Urine & Feces, Clinical Chemistry, Hematology, Self Monitoring of Blood Glucose (SMBG), Immunology, Infectious disease, Microbiology, Pathology and Genetic Testing) Companies (Abbott Laboratories, Danaher Corporation, Biomerieux, Roche Diagnostics, and Becton Dickinson), Reimbursements, Porter's Model, Growth Drivers, Opportunities Challenges” provides a complete analysis of Japan In Vitro Diagnostics (IVD) Market.

All the 11 Segments analysis of Japan In-Vitro Diagnostics Market

In this report, we have provided a complete analysis of 11 segments of the Japan In-vitro Diagnostic market. These segments are as follows Clinical Chemistry, Urine & Feces, Hematology, Tumor Marker, Self Monitoring Blood Glucose (SMBG), Immunology, Infectious disease, Microbiology, Pathology, Genetic Testing, and Others. In these In vitro diagnostics segments, we have done a comprehensive analysis of each segment due to COVID-19 along with separate growth factors for each segment.

Good Reimbursement Policy is expected ill further boost the Market of Japan In Vitro Diagnostics Market

Our report describes the scope and breadth of the reimbursement policies along with the full context. It also provides specific guidance and structure about how it operates and how Japanese authorities implement reimbursement policies. It describes how medical devices are categorized in Japan and which class In vitro diagnostic suits. It includes all medical manufacturers that have been in Japan for the past five years applying for reimbursement approval.

Porter's Five Forces Analysis

This research report provides a compressive study of all the 5 Porter's forces and their significant effect on Japan IVD industry.

BY Segment:

• Urine & Faces Diagnostics
• Hematology
• Clinical Chemistry
• Self-Blood Glucose Monitoring
• Tumor Marker
• Immunology
• Infectious Testing
• Microbiology
• Pathology
• Genetic Testing
• Others

All the companies given in the report has been studied from two points

• Recent Developments
• Sales Analysis

Company Analysis:

• Abbott Laboratories
• Danaher Corporation
• Biomerieux
• Roche Diagnostics
• Becton Dickinson


1. Introduction
2. Research Methodology
3. Executive Summery
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
4.3 Opportunities
5. Porter's Five Forces Analysis
5.1 Threat of New Entry
5.2 The Bargaining Power of Buyer
5.3 Threat of Substitution
5.4 The Bargaining Power of Supplier
5.5 Competitive Rivalry
6. Reimbursement Policy
7. Japan in Vitro Diagnostics Market
8. Market Share -Japan in Vitro Diagnostics
8.1 By Segment
9. Segments - Japan in Vitro Diagnostics Market
9.1 Urine & Faces Diagnostics
9.2 Hematology
9.3 Clinical Chemistry
9.4 Self-Blood Glucose Monitoring
9.5 Tumor Marker
9.6 Immunology
9.7 Infectious Testing
9.8 Microbiology
9.9 Pathology
9.10 Genetic Testing
9.11 Others
10. Company Analysis
10.1 Abbott Laboratories
10.1.1 Overview
10.1.2 Recent Development/Strategy
10.1.3 Sales
10.2 Danaher Corporation
10.2.1 Overview
10.2.2 Recent Development/Strategy
10.2.3 Sales
10.3 Biomerieux
10.3.1 Overview
10.3.2 Recent Development/Strategy
10.3.3 Sales
10.4 Roche Diagnostics
10.4.1 Overview
10.4.2 Recent Development/Strategy
10.4.3 Sales
10.5 Becton
10.5.1 Overview
10.5.2 Recent Development/Strategy
10.5.3 Sales
List of Figures:
Figure-01: Japan– In-vitro Diagnostic Market size (Million US$), 2018 & 2024
Figure-02: Japan– In-vitro Diagnostic Top Two Rapid Growing Segment 2020 - 2026
Figure-03: Japan– In-vitro Diagnostic Largest Market Share, Immunology (Percent), 2019 -2026
Figure-04: Japan- Age-related disease type (Percentage), 2005 - 2016
Figure-05: Japan - Healthcare expenditure GDP( Percentage) 2018-2030
Figure-06: Japna - Healthcare expenditure market (Billion US$), 2005 - 2025
Figure-07: Japan- Government Healthcare Spending for 75 and older Population ( Billion US$), 2015 - 2025
Figure-08: Japan – In-vitro Diagnostics Market (Million US$), 2012 – 2019
Figure-09: Japan – Forecast for In-vitro Diagnostics Market (Million US$), 2020 – 2026
Figure-10: Japan– Urine & Faces Diagnostics Market (Million US$), 2012 – 2019
Figure-11: Japan– Forecast for Urine & Faces Diagnostics Market (Million US$), 2020 – 2026
Figure-12: Japan– Hematology Market (Million US$), 2012 – 2019
Figure-13: Japan– Forecast for Hematology Market (Million US$), 2020 – 2026
Figure-14: Japan– Clinical Chemistry Market (Million US$), 2012 – 2019
Figure-15: Japan– Forecast for Clinical Chemistry Market (Million US$), 2020 – 2026
Figure-16: Japan– SMBG Market (Million US$), 2012 – 2019
Figure-17: Japan– Forecast for SMBG Market (Million US$), 2020 – 2026
Figure-18: Japan– Tumor Marker Market (Million US$), 2012 – 2019
Figure-19: Japan– Forecast for Tumor Marker Market (Million US$), 2020 – 2026
Figure-20: Japan– Immunology Market (Million US$), 2012 – 2019
Figure-21: Japan– Forecast for Immunology Market (Million US$), 2020 – 2026
Figure-22: Japan– Infectious Disease Market (Million US$), 2012 – 2019
Figure-23: Japan– Forecast for Infectious Disease Market (Million US$), 2020 – 2026
Figure-24: Japan– Microbiology Testing Market (Million US$), 2012 – 2019
Figure-25: Japan– Forecast for Microbiology Testing Market (Million US$), 2020 – 2026
Figure-26: Japan – Pathology Market (Million US$), 2012 – 2019
Figure-27: Japan– Forecast for Pathology Market (Million US$), 2020 – 2026
Figure-28: Japan – Genetic Testing Market (Million US$), 2012 – 2019
Figure-29: Japan – Forecast for Genetic Testing Market (Million US$), 2020 – 2026
Figure-30: Japan– Others Segment Market (Million US$), 2012 – 2019
Figure-31: Japan – Forecast for Others Market (Million US$), 2020 – 2026
Figure-32: Abbott Laboratories – Global Diagnostic Sales (Million US$), 2015 - 2019
Figure-33: Abbott Laboratories – Global Forecast for Diagnostic Sales (Million US$), 2020 – 2026
Figure-34: Danaher Corporation – Global Diagnostic Sales (Million US$), 2015 - 2019
Figure-35: Danaher Corporation – Global Forecast for Diagnostic Sales (Million US$), 2020 - 2026
Figure-36: Biomérieux– Global Diagnostic Sales (Million US$), 2015 - 2019
Figure-37: Biomérieux – Global Forecast for Diagnostic Sales (Million US$), 2020 - 2026
Figure-38: Roche Diagnostics – Global Diagnostics Division sales (Million US$), 2015 - 2019
Figure-39: Roche Diagnostics – Global Forecast for Diagnostics Division sales (Million US$), 2020 - 2026
Figure-40: Becton – Global Diagnostics System sales (Million US$), 2015 - 2019
Figure-41: Becton – Global Forecast for Diagnostics System sales (Million US$), 2020 - 2026
List of Tables:
Table-1: Growth Drivers % change 2005 - 2016
Table-2: Japan - Medical device & equipments reembursement policy
Table-3: Japan – In-vitro Diagnostics by Segment Market Share (Percent), 2012 – 2019
Table-4: Japan – Forecast for In-vitro Diagnostics by Segment Market Share (Percent), 2020 – 2026

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook